PHI with pancreatic carcinoma
How does this condition affect your private health insurance?
Pankreaskarzinom, or pancreatic cancer, is a malignant neoplasm arising from the pancreas, most commonly from the exocrine cells (adenocarcinoma). It is notoriously aggressive and often diagnosed at an advanced stage due to its insidious onset and non-specific symptoms like abdominal pain, weight loss, jaundice, and new-onset diabetes. Its anatomical location makes surgical resection challenging, and even when possible, recurrence rates are high. The tumor frequently metastasizes early to surrounding organs and distant sites. Treatment typically involves surgery, chemotherapy, and sometimes radiation, but prognosis remains poor, making it one of the deadliest cancers.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (from symptom onset to diagnosis and initial treatment)
Duration of Illness (Lifetime)
Typically months to a few years, often a rapidly progressing chronic disease
Cost of Treatment (Initial)
Very high (e.g., $50,000 - $200,000+ for surgery, chemotherapy, and initial care)
Cost of Treatment (Lifetime)
Extremely high (e.g., $100,000 - $500,000+ for ongoing chemotherapy, radiation, palliative care, and management of complications)
Mortality Rate
Very high (5-year survival rate is typically less than 10-15% overall)
Risk of Secondary Damages
Very high (e.g., severe weight loss, pain, diabetes, jaundice, ascites, organ failure, psychological distress)
Probability of Full Recovery
Very low (less than 5-10%, primarily in very early-stage, resectable cases)
Underlying Disease Risk
Moderate to high (e.g., chronic pancreatitis, diabetes, obesity, certain genetic syndromes like BRCA1/2 mutations, Peutz-Jeghers syndrome)